Log in

LON:BPCR - Biopharma Credit Share Price, Forecast & News

GBX 1.01
+0.01 (+1.00 %)
(As of 12/16/2019 04:46 AM ET)
Today's Range
Now: GBX 1.02
50-Day Range
52-Week Range
Now: GBX 1.02
Volume754,631 shs
Average Volume64,237 shs
Market Capitalization£13.95 million
P/E Ratio10.80
Dividend Yield6.86%
BioPharma Credit PLC, an investment trust, invests in interest-bearing debt assets secured by royalties or other cash flows derived from the royalties and sales of life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

Industry, Sector and Symbol

Industry Asset Management
SectorFinancial Services



Sales & Book Value

Annual Sales£141.97 million
Cash FlowGBX 44.91 per share
Book ValueGBX 102.60 per share



Outstanding Shares1,373,929,984
Market Cap£13.95 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BPCR News and Ratings via Email

Sign-up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter.

Biopharma Credit (LON:BPCR) Frequently Asked Questions

What is Biopharma Credit's stock symbol?

Biopharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR."

How often does Biopharma Credit pay dividends? What is the dividend yield for Biopharma Credit?

Biopharma Credit announced a dividend on Thursday, November 7th. Stockholders of record on Thursday, November 14th will be paid a dividend of GBX 0.02 per share on Tuesday, December 17th. This represents a dividend yield of 1.73%. The ex-dividend date is Thursday, November 14th. The official announcement can be accessed at this link. View Biopharma Credit's Dividend History.

Has Biopharma Credit been receiving favorable news coverage?

Press coverage about BPCR stock has been trending negative on Monday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Biopharma Credit earned a coverage optimism score of -2.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Biopharma Credit.

Who are some of Biopharma Credit's key competitors?

What other stocks do shareholders of Biopharma Credit own?

Who are Biopharma Credit's key executives?

Biopharma Credit's management team includes the folowing people:
  • Mr. Pedro Gonzalez de Cosio, Investment Mang.
  • Mr. Pablo G. Legorreta, Investment Mang.
  • Mr. Martin G. Friedman, Investment Mang. (Age 54)

How do I buy shares of Biopharma Credit?

Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Biopharma Credit's stock price today?

One share of BPCR stock can currently be purchased for approximately GBX 1.02.

How big of a company is Biopharma Credit?

Biopharma Credit has a market capitalization of £13.95 million and generates £141.97 million in revenue each year. View Additional Information About Biopharma Credit.

What is Biopharma Credit's official website?

The official website for Biopharma Credit is http://www.bpcruk.com/.

MarketBeat Community Rating for Biopharma Credit (LON BPCR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  173
MarketBeat's community ratings are surveys of what our community members think about Biopharma Credit and other stocks. Vote "Outperform" if you believe BPCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BPCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Featured Article: Earnings Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel